Rotech Healthcare Inc. to acquire Inogen, Inc.

Rotech Healthcare Inc. has agreed to acquire Inogen, Inc. in a cash transaction. The deal, announced on 30 September 2026, involves the purchase of assets from the target company. Both entities are based in the United States and operate within the healthcare sector. The specific financial value of the transaction has not been disclosed. This acquisition represents a strategic move for Rotech to expand its portfolio through the acquisition of Inogen’s assets. The consideration for the deal is structured entirely in cash, with no equity component mentioned in the available information.

The transaction is currently at the firm intention stage, indicating a strong commitment to proceed. No completion date has been reported, and the deal remains subject to standard closing conditions. Regulatory approvals and other customary conditions precedent must be satisfied before the transfer of assets can be finalized. The healthcare sector continues to see consolidation activity, with established players seeking to strengthen their market position through targeted acquisitions. This deal aligns with broader industry trends where companies focus on acquiring specific assets to enhance their operational capabilities and product offerings. The outcome will depend on the successful negotiation of final terms and the clearance of any remaining regulatory hurdles.